Blood tests after a heart attack to study heart strain markers
Part of Heart & circulation clinical trials.
This study looks at blood test “markers” soon after an acute heart attack, to better understand heart damage and whether heart failure is present. It may help doctors improve how they monitor recovery and risk in people after a heart attack.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You recently had a heart attack (acute myocardial infarction) confirmed by blood tests like troponin or CK-MB
- You may have heart failure symptoms or findings, or you may not
- If you are diagnosed with heart failure, it must be supported by imaging (like an echocardiogram) showing heart function or filling pressure problems
- If you are in the comparison group (control), you are a man age 60 or older with no past heart disease or heart attack
- You can give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a type of white blood cell (monocytes) in blood to understand differences in people with certain heart attacks, stable heart disease, or ischemic stroke. It may help researchers learn why these conditions happen and how the immune system may be involved.
This study looks at blood clotting (platelets) during the first phase after a heart attack. You may be able to join if you were recently diagnosed with a heart attack and received standard heart-attack blood thinners like aspirin and a second anti-platelet medicine.
This study looks at blood “biomarkers” (signals in blood tests) in people who arrive with symptoms that could be a heart attack. It may help doctors spot and manage acute heart problems sooner and more accurately.
This trial looks at how to assess small blood-vessel (microvascular) problems in people who had a heart attack but whose main heart arteries are not blocked. It may help doctors better find what’s driving symptoms and choose the right tests and treatments.
This study looks at new blood tests (biomarkers) that may predict whether blood flow will be blocked again after a stent procedure for a heart attack. It could help doctors improve treatment and recovery.
This study looks at blood “markers” (substances in the blood) to help explain how some people move from early heart strain to full heart failure. You may be enrolled if you have stable or worsening heart failure symptoms, or you may qualify as a healthy control for comparison.
Hear when a new Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.